Catherine A Spino

Top grants by award amount

Catherine A Spino's NIH grant portfolio, ranked by award amount.

• 5U24DK122927-06U24

  University of Michigan Data Coordinating Center for the Diabetic Foot Consortium

  University of Michigan
  $3.9M

  award amount
• 7R33HL158540-04R33

  Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients

  University of Massachusetts Medical School Worcester
  $1.8M

  award amount
• 5U24HL154946-04U24

  2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial

  University of Michigan
  $944K

  award amount
• 5U24HL145265-05U24

  Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study

  University of Michigan
  $627.2K

  award amount
• 5P50NS123067-04P50

  Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease

  University of Michigan
  $212.8K

  award amount
• 5R33HL158540-03R33

  Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients

  Weill Cornell Medicine
  $48.1K

  award amount

Affiliations

Institutions that have administered grants for Catherine A Spino.

Career milestones

Key NIH funding milestones over time.

1. 2024
   First NIH Award
   University of Michigan
2. 2024
   $500K Cumulative Funding
3. 2024
   $1M Cumulative Funding
4. 2024
   $2M Cumulative Funding
5. 2024
   $5M Cumulative Funding
6. 2024
   Entered Top 50% Nationally
   Ranked #573
7. 2024
   Entered Top 25% Nationally
   Ranked #573
8. 2024
   Entered Top 10% Nationally
   Ranked #573
9. 2024
   Entered Top 5% Nationally
   Ranked #573
10. 2024
    Multi-Institutional Research
    Awards at 3 institutions

Related investigators

Other NIH-funded PIs frequently associated with Catherine A Spino.